However, CFS might not be the official designation for this illness much longer. A group of scientists and patients has been working for the past two years to come up with a new name and expects to present it to the federal government's CFS Advisory Committee in the next few months. With committee approval, it would go on to the U.S. Secretary of Health and Human Services, Tommy Thompson, who can make it official, Jason says. The new name -- neuroendocrineimmune dysfunction syndrome, or NDS -- better represents the illness, Jason says. "The term is broad enough to encompass the most commonly reported symptoms [which] are associated with or referable to the neurologic, neuroendocrine and immunologic systems," states a paper prepared by the group proposing the name change. Continued use of the term "syndrome" recognizes that it's a "collection of signs and symptoms that in their totality define this illness," the group says. And, the group adds, that also should help NDS to gain acceptance by the medical community.